BNP Paribas Financial Markets’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.8M | Buy |
407,068
+117,066
| +40% | +$10.7M | 0.02% | 821 |
|
|
2025
Q4 | $26.1M | Sell |
290,002
-58,655
| -17% | -$5.56M | 0.01% | 1025 |
|
|
2025
Q3 | $34.3M | Sell |
348,657
-76,310
| -18% | -$7.56M | 0.02% | 799 |
|
|
2025
Q2 | $38.8M | Buy |
424,967
+10,862
| +3% | +$1.05M | 0.02% | 697 |
|
|
2025
Q1 | $46.9M | Buy |
414,105
+34,976
| +9% | +$3.74M | 0.03% | 626 |
|
|
2024
Q4 | $40M | Buy |
379,129
+225,092
| +146% | +$24.2M | 0.02% | 716 |
|
|
2024
Q3 | $16.6M | Sell |
154,037
-54,250
| -26% | -$5.92M | 0.01% | 949 |
|
|
2024
Q2 | $22.6M | Sell |
208,287
-38,633
| -16% | -$4.55M | 0.02% | 718 |
|
|
2024
Q1 | $32.6M | Buy |
246,920
+45,522
| +23% | +$5.69M | 0.03% | 560 |
|
|
2023
Q4 | $24.5M | Buy |
201,398
+2,995
| +2% | +$334K | 0.03% | 609 |
|
|
2023
Q3 | $22.3M | Sell |
198,403
-137
| -0.1% | -$17.4K | 0.03% | 559 |
|
|
2023
Q2 | $28.9M | Buy |
198,540
+39,045
| +24% | +$5.31M | 0.04% | 470 |
|
|
2023
Q1 | $20.6M | Buy |
159,495
+74,577
| +88% | +$9.36M | 0.03% | 579 |
|
|
2022
Q4 | $10.8M | Sell |
84,918
-135,145
| -61% | -$15.7M | 0.02% | 939 |
|
|
2022
Q3 | $23M | Buy |
220,063
+148,117
| +206% | +$16.3M | 0.04% | 568 |
|
|
2022
Q2 | $7.56M | Sell |
71,946
-35,208
| -33% | -$4.18M | 0.01% | 1045 |
|
|
2022
Q1 | $13.7M | Buy |
107,154
+60,674
| +131% | +$7.31M | 0.02% | 769 |
|
|
2021
Q4 | $5.73M | Sell |
46,480
-134,158
| -74% | -$17.6M | 0.01% | 1260 |
|
|
2021
Q3 | $25.7M | Sell |
180,638
-6,689
| -4% | -$984K | 0.04% | 508 |
|
|
2021
Q2 | $29.2M | Buy |
187,327
+1,871
| +1% | +$303K | 0.04% | 485 |
|
|
2021
Q1 | $28.8M | Sell |
185,456
-31,496
| -15% | -$4.88M | 0.04% | 426 |
|
|
2020
Q4 | $32.5M | Buy |
216,952
+23,509
| +12% | +$3.32M | 0.06% | 328 |
|
|
2020
Q3 | $25.6M | Sell |
193,443
-34,036
| -15% | -$4.45M | 0.04% | 442 |
|
|
2020
Q2 | $26.4M | Sell |
227,479
-99,279
| -30% | -$11.4M | 0.05% | 368 |
|
|
2020
Q1 | $32.1M | Buy |
326,758
+104,854
| +47% | +$13.7M | 0.07% | 274 |
|
|
2019
Q4 | $32.2M | Buy |
221,904
+203,471
| +1,104% | +$28.1M | 0.06% | 353 |
|
|
2019
Q3 | $2.46M | Buy |
18,433
+1,458
| +9% | +$188K | ﹤0.01% | 1401 |
|
|
2019
Q2 | $1.94M | Buy |
16,975
+8,591
| +102% | +$1.01M | ﹤0.01% | 1471 |
|
|
2019
Q1 | $1.04M | Sell |
8,384
-14,239
| -63% | -$1.62M | ﹤0.01% | 1677 |
|
|
2018
Q4 | $2.28M | Sell |
22,623
-46,318
| -67% | -$5.21M | 0.01% | 1261 |
|
|
2018
Q3 | $8.8M | Sell |
68,941
-11,473
| -14% | -$1.36M | 0.01% | 891 |
|
|
2018
Q2 | $8.7M | Buy |
80,414
+34,332
| +75% | +$3.74M | 0.01% | 851 |
|
|
2018
Q1 | $4.88M | Sell |
46,082
-16,782
| -27% | -$1.95M | 0.01% | 1005 |
|
|
2017
Q4 | $7.36M | Sell |
62,864
-64,525
| -51% | -$7.3M | 0.01% | 869 |
|
|
2017
Q3 | $14.5M | Buy |
127,389
+19,512
| +18% | +$2.25M | 0.04% | 456 |
|
|
2017
Q2 | $13.4M | Sell |
107,877
-64,373
| -37% | -$7.63M | 0.04% | 425 |
|
|
2017
Q1 | $20.4M | Buy |
172,250
+163,333
| +1,832% | +$18.5M | 0.05% | 354 |
|
|
2016
Q4 | $893K | Sell |
8,917
-79,196
| -90% | -$8.49M | ﹤0.01% | 1393 |
|
|
2016
Q3 | $11.1M | Buy |
88,113
+64,329
| +270% | +$7.95M | 0.05% | 275 |
|
|
2016
Q2 | $2.78M | Sell |
23,784
-4,407
| -16% | -$499K | 0.01% | 705 |
|
|
2016
Q1 | $2.92M | Buy |
28,191
+15,805
| +128% | +$1.53M | 0.01% | 724 |
|
|
2015
Q4 | $1.23M | Sell |
12,386
-125,682
| -91% | -$12.3M | ﹤0.01% | 1054 |
|
|
2015
Q3 | $12.6M | Buy |
138,068
+106,810
| +342% | +$10.7M | 0.03% | 363 |
|
|
2015
Q2 | $3.31M | Buy |
31,258
+5,321
| +21% | +$589K | 0.01% | 692 |
|
|
2015
Q1 | $2.96M | Sell |
25,937
-61,865
| -70% | -$7.06M | 0.01% | 753 |
|
|
2014
Q4 | $9.67M | Buy |
87,802
+5,623
| +7% | +$593K | 0.03% | 446 |
|
|
2014
Q3 | $8.02M | Buy |
82,179
+36,960
| +82% | +$3.64M | 0.01% | 578 |
|
|
2014
Q2 | $4.56M | Sell |
45,219
-30,702
| -40% | -$3M | ﹤0.01% | 693 |
|
|
2014
Q1 | $7.14M | Sell |
75,921
-19,963
| -21% | -$1.84M | 0.01% | 560 |
|
|
2013
Q4 | $8.68M | Buy |
95,884
+2,975
| +3% | +$257K | 0.01% | 502 |
|
|
2013
Q3 | $7.41M | Buy |
92,909
+86,209
| +1,287% | +$6.79M | 0.01% | 598 |
|
|
2013
Q2 | $487K | Buy |
+6,700
| New | +$501K | ﹤0.01% | 1583 |
|
Other funds holding ZBH
VCM
VPM
BNP Paribas Financial Markets's ZBH Position: Q1 2026 in Review
BNP Paribas Financial Markets increased its Zimmer Biomet (ZBH) stake by 40% in Q1 2026, buying an estimated $10.7M and bringing the position to 407,068 shares worth $36.8M. The position accounts for 0.02% of the portfolio, ranked #821.
BNP Paribas Financial Markets first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $46.9M in Q1 2025. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.
- BNP Paribas Financial Markets held 407,068 shares of Zimmer Biomet worth $36.8M as of Q1 2026.
- BNP Paribas Financial Markets bought 117,066 Zimmer Biomet shares in Q1 2026, an estimated $10.7M.
- Zimmer Biomet made up 0.02% of BNP Paribas Financial Markets's portfolio in Q1 2026, its #821 holding.
- BNP Paribas Financial Markets first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
- BNP Paribas Financial Markets's Zimmer Biomet position peaked at $46.9M in Q1 2025.
- 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2026, filed 12 May 2026.